Date: 2013-02-05
Type of information: Licensing agreement
Compound: EB66® cell line
Company: Vivalis (France) Fatro (Italy)
Therapeutic area: Veterinary Medicine
Type agreement: licensing
Action mechanism:
Disease:
Details: Vivalis has signed a research license agreement with the Italian animal health vaccine company Fatro. This license allows for the assessment of several viruses in EB66® cells. Terms of the agreement were not disclosed.
Financial terms:
Latest news:
